Linda Muroski, President of Trelleborg Healthcare & Medical, says: “The site will initially add over 370 square meters/4,000 square feet of cleanroom space and focus on silicone tubing and braided hose with options to extend capabilities in the future. This is Trelleborg’s second biopharma-focused manufacturing space alongside our BioPharma Center of Excellence in Northborough, Massachusetts in the US.”
The Malta site is one of Trelleborg’s largest manufacturing sites in Europe with a history of more than 60 years in advanced elastomeric solutions. Currently, the main site in Hal Far consists of three buildings and construction has already begun on a fourth adjacent block. The facility is set for completion by the end of 2023 with production starting early 2024.
Courtesy of Trelleborg.
